Arkolith/Insider Trading/OCX/Form 4

Arno Andrew

DirectorOncocyte Corp (OCX) · full profile →Form 4 · filed Aug 17, 2022
Net Buying
Open-Market Buys
$144K
Open-Market Sells
$0
Net Open-Market Flow
$144K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 16, 2022Buy(P)116K$0.97$112K282K
Aug 15, 2022Buy(P)34K$0.93$32K167K
Aug 15, 2022Grant(A)10K—$0132K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 15, 2022Grant(A)45K—$045K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-22-023373) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML